“We need more than just random care. We need randomized care.”

–  Dr. Derek Chu

For years, the allergy world has been drowning in a sea of data—risk factors, prevention strategies, and enough diagnostic tools to fill a warehouse. But how do you translate 340 different risk factors into a cohesive plan when an anxious parent is sitting in your clinic demanding a skin test for their four-month-old?. On this episode, our host is joined by “systematic review genius” Dr. Derek Chu to unpack the evidence-based roadmap for food allergy and atopic dermatitis. It’s time to move past the “noise” and start reading between the lines of what our patients actually need.

On this episode, they discuss:

• Major vs. Minor Signals: Eczema severity and family history are the big players, while being first-born or male are merely minor notes in the risk profile.
• The Diagnostic Trap: Testing only works if it changes practice; otherwise, you’re just putting a baby through the trauma of an itchy back for a 20% certainty bump.
• De-escalating Momentum: Be skeptical of previous “avoid all nuts” labels; if the patient is already eating the food, do not skin test them to it.
• The TITAN Initiative: We need national, high-quality food challenge capacity to provide the clarity that families are actually looking for.
• Beyond Narrative Synthesis: The new eczema guidelines involve patients as partners and weigh everything from JAK inhibitors to the humble (but low-certainty) bleach bath.
• Clean Hands, Frequent Moisture: Prevention of atopic dermatitis may be gray, but moisturizing with every diaper change—using clean hands—is a low-stakes win

Dr. Chu walks us through the “diagnostic momentum” that often leads clinicians to over-test and over-restrict, and why your Royal College exam cutoffs might not be as definitive as you remember. From the major and minor predictors of food allergy to the “multimorbid” patient with eczema, this conversation is a masterclass in being sensible and judicious at the bedside.

Posted on April 28, 2026.